(Q38976135)

English

Aberrant serum immunoglobulin G glycosylation in chronic hepatitis B is associated with histological liver damage and reversible by antiviral therapy

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Aberrant serum immunoglobulin G glycosylation in chronic hepatitis B is associated with histological liver damage and reversible by antiviral therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

1 reference

based on heuristic

inferred from title

chronic hepatitis B

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

author name string

Cheng-Hsun Ho

1

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Rong-Nan Chien

2

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Pin-Nan Cheng

3

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Jia-Huei Liu

4

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Cheng-Kun Liu

5

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Chih-Sheng Su

6

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

I-Chin Wu

7

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

I-Chen Li

8

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Hung-Wen Tsai

9

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Shiaw-Lin Wu

10

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Wen-Chun Liu

11

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Shu-Hui Chen

12

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Ting-Tsung Chang

13

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

language of work or name

0 references

publication date

10 July 2014

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Journal of Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

211

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

115-124

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Hepatitis B Virus Infection

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU388

21 January 2018

Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU388

21 January 2018

Immunoglobulins in chronic liver disease

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU388

21 January 2018

Detailed glycan analysis of serum glycoproteins of patients with congenital disorders of glycosylation indicates the specific defective glycan processing step and provides an insight into pathogenesis

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU388

21 January 2018

A comparative study of the N-linked oligosaccharide structures of human IgG subclass proteins

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU388

21 January 2018

The influence of glycosylation on the thermal stability and effector function expression of human IgG1-Fc: properties of a series of truncated glycoforms.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU388

21 January 2018

Role of oligosaccharide residues of IgG1-Fc in Fc gamma RIIb binding

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU388

21 January 2018

Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU388

21 January 2018

IgG glycosylation analysis

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU388

21 January 2018

Immunoglobulins are the major glycoproteins involved in the modifications of total serum N-glycome in cirrhotic patients.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU388

21 January 2018

Increased Levels of Galactose-Deficient Anti-Gal Immunoglobulin G in the Sera of Hepatitis C Virus-Infected Individuals with Fibrosis and Cirrhosis

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU388

21 January 2018

Immunoglobulin G Fc N-glycan profiling in patients with gastric cancer by LC-ESI-MS: relation to tumor progression and survival.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU388

21 January 2018

Fcgamma receptors as regulators of immune responses

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU388

21 January 2018

A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU388

21 January 2018

Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU388

21 January 2018

Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU388

21 January 2018

Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU388

21 January 2018

Serum beta-N-acetylglucosaminidase, beta-D-glucosidase, alpha-D-glucosidase, beta-D-fucosidase, alpha-L-fucosidase and beta-D-galactosidase levels in acute viral hepatitis, pancreatitis, myocardial infarction and breast cancer.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU388

21 January 2018

The effect on IgG glycosylation of altering beta1, 4-galactosyltransferase-1 activity in B cells

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU388

21 January 2018

Agalactosyl glycoforms of IgG autoantibodies are pathogenic

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU388

21 January 2018

Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU388

21 January 2018

The immunoglobulin, IgG Fc receptor and complement triangle in autoimmune diseases

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU388

21 January 2018

Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU388

21 January 2018

Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU388

21 January 2018

Identifiers

10.1093/INFDIS/JIU388

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38976135&oldid=1800450219"